Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Oncolytic and local immunotherapy

Original research

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Online download statistics by month:

Online download statistics by month: April 2021 to December 2022

	Abstract	Full	Pdf
Apr 2021	744	744	164
May 2021	531	531	133
Jun 2021	247	247	117
Jul 2021	169	169	50
Aug 2021	179	177	36
Sep 2021	176	176	46
Oct 2021	188	188	64
Nov 2021	194	193	81
Dec 2021	166	170	55
Jan 2022	125	131	72
Feb 2022	108	113	83
Mar 2022	126	129	57
Apr 2022	142	154	74
May 2022	145	158	70
Jun 2022	99	99	47
Jul 2022	97	99	56
Aug 2022	141	146	46
Sep 2022	106	107	28
Oct 2022	86	99	61
Nov 2022	76	78	39
Dec 2022	93	93	37
Total	3938	4001	1416